Filter
1319
Filtered Results: 1319
Text search:
Pharmacology
Featured
Recommendations
150
New Publications
247
Language
Document type
No document type
676
Guidelines
252
Studies & Reports
201
Manuals
79
Strategic & Response Plan
33
Fact sheets
32
Training Material
28
Situation Updates
7
Resource Platforms
5
Brochures
2
Infographics
2
Online Courses
2
Countries / Regions
India
87
Global
57
South Africa
41
Kenya
32
Western and Central Europe
31
Ethiopia
21
Latin America and the Carribbean
18
Nigeria
17
Russia
15
Nepal
14
Ukraine
14
Rwanda
14
Africa
14
Germany
13
Uganda
13
Eastern Europe
13
Sierra Leone
12
Syria
11
Ghana
10
Zimbabwe
10
Tanzania
10
Brazil
10
Philippines
9
Congo, Democratic Republic of
9
Bangladesh
9
Zambia
9
Asia
8
Malawi
7
Indonesia
7
Eswatini/ Swaziland
7
Cameroon
6
Lesotho
5
Senegal
5
Burkina Faso
5
Mozambique
5
South–East Asia Region
5
Namibia
5
South Sudan
5
Myanmar / Burma
5
USA
4
Haiti
4
Argentina
4
Botswana
4
Madagascar
4
West and Central Africa
3
Eastern Europe and Central Asia
3
East and Southern Africa
3
Angola
3
Iraq
3
Liberia
3
North Macedonia
2
Tajikistan
2
Benin
2
Chile
2
Canada
2
Peru
2
Guinea
2
Guinea-Bissau
2
Middle East and North Africa
2
Western Pacific Region
2
North America
2
Jamaica
2
Papua New Guinea
2
Ecuador
2
Thailand
1
China
1
Kazakhstan
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Cambodia
1
Hungary
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Spain
1
Southern Africa
1
Bolivia
1
Lebanon
1
Sri Lanka
1
Sudan
1
Georgia
1
Central African Republic
1
Poland
1
Mali
1
Bhutan
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
406
Clinical Guidelines
164
Public Health
93
Women & Child Health
56
Pharmacy & Technologies
19
Capacity Building
11
Key Resources
6
Toolboxes
Mental Health
331
Pharmacy
101
AMR
83
NCDs
81
COVID-19
80
Caregiver
55
HIV
49
TB
48
NTDs
28
Conflict
19
Rapid Response
18
Planetary Health
15
Refugee
12
Disability
11
Ebola
10
Specific Hazards
8
Global Health Education
8
Natural Hazards
4
Zika
3
Social Ethics
2
Health Financing Toolbox
2
Polio
2
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
Q9: What is/are the effective and safe interventions to treat somatoform disorders in children and adolescents in non- specialist health settings?
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
Q8: What is the effectiveness, safety and role of pharmacological interventions, by non-specialized health care providers, for the broad category of Disruptive Behaviour Disorders (DBDs), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid (but not exclusively) Attention-Deficit ...
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
Externalizing disorders
Chapter 1.1
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
International Journal of Psychiatry in Clinical Practice, 2012; 16: 77–84
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Hea...
The document provides a summary of recommendations for the non-pharmacological management of chronic obstructive pulmonary disease (COPD) and the use of inhaled therapies in individuals over 16, emphasizing confirmed diagnosis, treatment options, and regular review of treatment effectiveness and inh...
The global epidemic of type 2 Diabetes Mellitus (T2DM) presents significant challenges to world health both in terms of financial costs as well as morbidity. Thus, considerable research has been focussed on the prevention or delay of the onset of T2DM.
Type 2 Diabetes Mellitus (T2DM) is one of the ...
